Search Results
Site Search
Week in Review: April 22 - Insights
Today's highlights include: Study mines cancer genetics to help with targeted treatment, Mayo Clinic to launch staffing tool app to find 'right nurse for the right role', and new blood biomarker may lead to early diagnosis of frontotemporal...
Testing Archives - Page 22 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 22 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Answers From the Lab Archives - Page 22 of 28 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Clinic Laboratory and Pathology Research Roundup: Oct. 22 - Insights
This week’s Research Roundup highlights neoantigenic potential of complex chromosomal rearrangements in mesothelioma.
Clinic Laboratory and Pathology Research Roundup: May 22 - Insights
This week’s Research Roundup highlights the management of diffuse low-grade gliomas in adults.
Laboratory and pathology research roundup: March 22 - Insights
This Feature Includes: A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.
Clinic Laboratory and Pathology Research Roundup: Jan. 22 - Insights
This week’s Research Roundup highlights improving immune-vascular crosstalk for cancer immunotherapy.
Laboratory and pathology research roundup: November 22 - Insights
This week's research roundup features: Progression of chronic kidney disease following radical and partial nephrectomy
COVID-19 weekly news: May 16-22 2022 - Insights
Topics include: COVID-19 update, tips for navigating a return to work with long COVID, and COVID-19 booster vaccinations extended to kids 5-11.
Laboratory and pathology research roundup: August 22 - Insights
This week's research roundup feature: Association of plasma biomarkers of Alzheimer Disease with cognition and medical comorbidities in a biracial cohort.
participate in the American Academy of Neurology Annual Meeting, taking place in person in Boston on April 22–27, 2023....
New tests launched in May - Insights
In May 2023, Mayo Clinic Laboratories announced 22 new tests along with numerous reference value changes, obsolete tests, and algorithm changes....
Comprehensive drug urine profiles - Insights
Able to detect 22 drug classes, our comprehensive addiction medicine profile can help identify polysubstance use disorder as well as assess and manage patients at risk for substance use disorder....
Giving thanks for years of prostate cancer treatment: Kurt Glover-Ettrich - Insights
career in the U.S. military. Today, as a Mayo Clinic volunteer, Kurt is giving back in new ways for the 22 years of regular care, treatment, and laboratory testing he’s received in response to the prostate...
Intestinal Infection Testing - Mayo Clinic Laboratories
multiplex polymerase chain reaction (PCR) test capable of rapidly and qualitatively detecting DNA or RNA of 22 pathogens (13 bacteria, 5 viruses, and 4 parasites)....
On the April 22 broadcast of Mayo Clinic Radio, co-hosts Tracy McCray and Tom Shives, M.D., spoke with Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory, about an update on Lyme disease...
Earth Day, Saturday, April 22, is one day when most folks pay particularly close attention to protecting the environment. This year, we're finding inspiration in the Sisters of Saint Francis who helped...
New high-resolution urine drug testing profile - Insights
approach, Mayo Clinic Laboratories’ new high-resolution urine drug testing profile, ADMPU, evaluates for 22 drug classes including alcohol, marijuana, and nicotine, enabling clarity on substance use and precision...
Appropriate Use of Gastrointestinal Pathogen Panel by PCR [Utilization Spotlight] - Insights
test delivering rapid and cost-effective testing results. It is capable of detecting DNA or RNA of 22 pathogens in approximately 1 hour from stool submitted to the laboratory....
Transfusion Decisions - Insights
PACE / State of FLIn this month’s “Virtual Lecture” Justin Kreuter, M.D., discusses how coagulation works and how to make appropriate transfusion decisions.
Autoimmune Myelopathy - Insights
The clinical, radiologic, and serologic characteristics of autoimmune myelopathies and their mimics.
In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., speaks with career educator, Elissa Hall, Ed.D., on the integration and impact of artificial intelligence in graduate medical education, exploring strategies for teaching AI, the...
Due to a major weather impact at the FedEx hub in Memphis, Tennessee, the Mayo Clinic Laboratories’ Global Logistics team is working to minimize any client impacts. Please visit our website for updates. For any immediate needs, please...
Why Urinalysis Is My Favorite Course - Insights
Nikiesha Myers, a student in Mayo Clinic’s Medical Laboratory Science class of 2018, talks about why Urinalysis has been her favorite course in the program.
Is the term "outreach" obsolete? - Insights
In a competitive outpatient testing market, choosing a laboratory is discretionary. With the goal of becoming the laboratory of choice for discretionary outpatient testing, it no longer matters if it is called “inreach” or “outreach.” While...
Legal Updates in Phlebotomy - Insights
This "Phlebotomy" webinar will provide an update of litigation trends affecting phlebotomists.
Transfusion Toons: Coombs Full - Insights
Justin Kreuter, M.D., Clinical Pathologist and Medical Director of the Mayo Clinic Blood Donor Center in Rochester, Minnesota, and Theresa Malin, an Education Specialist in Transfusion Medicine at Mayo Clinic, have launched “Transfusion...
Linda Hasadsri, M.D., Ph.D., explains carrier screening at Mayo Clinic Laboratories. Using targeted genotyping, our three focused panels evaluate genes associated with cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies, to...
PD-L1 Testing by Immunohistochemistry - Insights
In this month's "Hot Topic," Anja Roden, M.D., discusses the role of PD-L1 interaction in the immune system, challenges of PD-L1 testing, and current PD-L1 companion testing in various tumor types.
MCL @Work: Brie LaJoye - Insights
Brie LaJoye began her career with Mayo Clinic in 2018 as an intern and has been with the organization for nearly six years. She currently works as a Laboratory information system (LIS) technical specialist, managing lab instrumentation,...
Stiff-Person/PERM Evaluation - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' stiff-person assay provides comprehensive evaluation for individuals on the spectrum of stiff-person syndrome. In addition to guiding treatment decisions, the assay...
Predictions for 2023: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo...
New Test Options for NTRK Gene Fusions - Insights
The presence NTRK gene fusions is one of the eligibility requirements for the recently FDA-approved therapy Vitrakvi (larotrectinib), a therapy indicated in adult and pediatric patients with solid tumors regardless of the type of tumor....
Helicobacter pylori testing: 2021 update - Insights
In this month’s Hot Topic, Robin Patel, M.D., discusses Mayo Clinic Laboratories’ new PCR assay for detection of Helicobacter pylori detection and determination of clarithromycin resistance directly from stool.
Autoimmune Peripheral Neuropathy: A New Paradigm Shift - Insights
PACE/State of FL - This webinar will discuss the advantages of using electrophysiology results to guide the selection of axonal or demyelinating testing for peripheral neuropathy. This approach can help identify specific antibodies...
Applying Mayo Clinic MASSFIX to Urine Samples - Insights
In this month's "Hot Topic," David Murray, M.D., Ph.D., reviews the role of urine testing for monoclonal gammopathies and discusses Mayo Clinic’s use of MASSFIX to replace traditional immunofixation testing.
The Expanding Reach of the Laboratory Outreach Program - Insights
The most successful laboratory outreach programs recognize the importance of serving multiple customers. From provider to patient to healthcare consumer, the laboratory has an opportunity to serve them all with high-quality results and...
Thank you for your collaboration in 2023 - Insights
Mayo Clinic Laboratories is grateful for the opportunity to serve you and other healthcare professionals around the globe in providing critical answers and actionable insights.
Staffing to Workload in Phlebotomy Areas: Indirect Effort - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on indirect effort, which includes tasks performed that don’t involve the patient or a patient’s sample.
Evacuation of a Health Care Facility: When Disaster Strikes - Insights
Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, discusses the evacuation of a health care facility when disaster strikes.
QuantiFERON-TB Gold Plus - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D. will discuss a new interferon-gamma release assay that can assist in the detection of individuals that are infected with tuberculosis.
Advocating for lab legislation: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi...
Kelch-11 Autoantibody Test [Test in Focus] - Insights
Divyanshu (Div) Dubey, M.B.B.S., explains how Mayo Clinic Labs’ new Kelch-11 antibody test — the first in the world — can confirm diagnosis, guide treatment, and improve outcomes in patients affected by testicular cancer-associated...
Establishing a trusted lab partner in an evolving landscape - Insights
William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, authored a Becker’s Healthcare article on how hospital laboratories can navigate times of change and uncertainty with the steadfast support...
Featured new tests in quarter two of 2025 - Insights
In the second quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.
Applications of Molecular Pathology and the Diagnosis of Soft Tissue Neoplasms - Insights
PACE / State of FLIn this month’s “Virtual Lecture” Andrew Folpe, M.D., discusses applications of molecular pathology and the diagnosis of soft tissue neoplasms. This presentation is applicable for pathologists because so much of what is...
CPT Codes and LOINC Update: June 2019 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of June 2019.
1939: Lou Gehrig Comes to Mayo Clinic #ThrowbackThursday - Insights
They called him the "Iron Horse" and the "Pride of the Yankees." But when baseball great Lou Gehrig came to Mayo Clinic in June 1939, his name became associated with an illness called amyotrophic lateral sclerosis (ALS). Today, ALS is known...
Laboratory Finance: Make Every Dollar Work for You - Insights
Interested in understanding laboratory finance and how to make every dollar work for you? Jane Hermansen, Manager of Outreach and Network Development at Mayo Clinic Laboratories, provides insight on how to define revenue streams, clearly...